Diabetes

Add-on sitagliptin cuts risk of insulin initiation in T2DM

(HealthDay)—For patients with type 2 diabetes mellitus (T2DM) treated with metformin, add-on sitagliptin is associated with a lower risk of insulin initiation than add-on sulphonylurea, according to a study published in ...

Medical research

Diabetes drug metformin makes brain cells grow

The widely used diabetes drug metformin comes with a rather unexpected and alluring side effect: it encourages the growth of new neurons in the brain. The study reported in the July 6th issue of Cell Stem Cell also finds ...

Diabetes

Which diabetes drug is best?

(HealthDay)—No single drug to treat type 2 diabetes stands out from the pack when it comes to reducing the risks of heart disease, stroke or premature death, a new research review finds.

Medications

How a widely used diabetes medication actually works

Physicians have used the drug metformin to treat type 2 diabetes for more than half a century, but despite its prevalence, researchers have lacked a clear understanding of how it works. Now, Yale researchers have elucidated ...

Diabetes

Effectiveness of canagliflozin in treating type 2 diabetes

Research led by the University of Dundee has found that one of a new breed of drugs, which have been approved for treatment of type 2 diabetes, may be particularly effective without the need to be used in combination with ...

Medications

A new method of action for an older anti-diabetic drug discovered

A research team led by Kobe University Graduate School of Medicine's Professor OGAWA Wataru (the Division of Diabetes and Endocrinology) and Project Associate Professor NOGAMI Munenobu (the Department of Radiology) has discovered ...

page 5 from 31